ATE408708T1 - Mutationen in verbindung mit eisenerkrankungen - Google Patents

Mutationen in verbindung mit eisenerkrankungen

Info

Publication number
ATE408708T1
ATE408708T1 AT00919650T AT00919650T ATE408708T1 AT E408708 T1 ATE408708 T1 AT E408708T1 AT 00919650 T AT00919650 T AT 00919650T AT 00919650 T AT00919650 T AT 00919650T AT E408708 T1 ATE408708 T1 AT E408708T1
Authority
AT
Austria
Prior art keywords
mutations associated
iron
diseases
disorder
iron diseases
Prior art date
Application number
AT00919650T
Other languages
English (en)
Inventor
Barry Rothenberg
Ritsuko Sawada-Hirai
James Barton
Original Assignee
Billups Rothenberg Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23060955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE408708(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Billups Rothenberg Inc filed Critical Billups Rothenberg Inc
Application granted granted Critical
Publication of ATE408708T1 publication Critical patent/ATE408708T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00919650T 1999-03-26 2000-03-24 Mutationen in verbindung mit eisenerkrankungen ATE408708T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/277,457 US6355425B1 (en) 1999-03-26 1999-03-26 Mutations associated with iron disorders

Publications (1)

Publication Number Publication Date
ATE408708T1 true ATE408708T1 (de) 2008-10-15

Family

ID=23060955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00919650T ATE408708T1 (de) 1999-03-26 2000-03-24 Mutationen in verbindung mit eisenerkrankungen

Country Status (8)

Country Link
US (5) US6355425B1 (de)
EP (1) EP1165840B1 (de)
AT (1) ATE408708T1 (de)
AU (2) AU779052B2 (de)
CA (1) CA2368802C (de)
DE (1) DE60040276D1 (de)
NZ (1) NZ514582A (de)
WO (1) WO2000058515A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674681A (en) * 1994-12-06 1997-10-07 Rothenberg; Barry E. Methods to identify hemochromatosis
US6140305A (en) 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US6355425B1 (en) * 1999-03-26 2002-03-12 Billups-Rothenberg, Inc. Mutations associated with iron disorders
US7324963B1 (en) * 2001-11-08 2008-01-29 At&T Delaware Intellectual Property, Inc. Methods and systems for offering bundled goods and services
US7767599B2 (en) 2006-10-10 2010-08-03 E.I. Du Pont De Nemours And Company Multidenier fiber cut resistant fabrics and articles
WO2008079877A2 (en) * 2006-12-22 2008-07-03 Xenon Pharmaceuticals Inc. Compositions and methods for the diagnosis and treatment of iron-related disorders
EP2576823A1 (de) 2010-06-04 2013-04-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Konstitutiv aktive prolactin-rezeptorvarianten als prognostische marker und therapeutische ziele zur vorbeugung des fortschritts von hormonabhängigen karzinomen in richtung hormonunabhängigkeit
US10694962B2 (en) * 2011-06-13 2020-06-30 Cedars-Sinai Medical Center Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
WO2012174157A1 (en) 2011-06-13 2012-12-20 Cedars-Sinai Medical Center Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
WO2016057242A1 (en) * 2014-10-10 2016-04-14 The Board Of Regents Of The University Of Texas System HIF-2α INHIBITORS FOR TREATING IRON OVERLOAD DISORDERS

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3774620A (en) * 1971-06-14 1973-11-27 Nemectron Gmbh Electromedicinal apparatus for interference current therapy
US3895639A (en) * 1971-09-07 1975-07-22 Rodler Ing Hans Apparatus for producing an interference signal at a selected location
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5094242A (en) * 1988-11-07 1992-03-10 Regents Of The University Of California Implantable nerve stimulation device
CA2101774C (en) 1991-01-21 2011-01-04 John A. Hardy Test and model for alzheimer's disease
FR2677372B1 (fr) 1991-06-06 1994-11-10 Pasteur Institut Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
US5193539A (en) * 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Implantable microstimulator
US5193540A (en) * 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Structure and method of manufacture of an implantable microstimulator
US5338662A (en) * 1992-09-21 1994-08-16 Bio-Preserve Medical Corporation Organ perfusion device
FR2704151B1 (fr) * 1993-04-21 1995-07-13 Klotz Antoine Olivier Dispositif électronique destiné à la stimulation adrénergique du système sympathique relatif à la média veineuse.
US5705343A (en) 1995-05-08 1998-01-06 Mercator Genetics, Inc. Method to diagnose hereditary hemochromatosis
US5753438A (en) 1995-05-08 1998-05-19 Mercator Genetics, Inc. Method to diagnose hereditary hemochromatosis
US6051017A (en) * 1996-02-20 2000-04-18 Advanced Bionics Corporation Implantable microstimulator and systems employing the same
US6140305A (en) * 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US6025130A (en) 1996-04-04 2000-02-15 Mercator Genetics, Inc. Hereditary hemochromatosis gene
US5712098A (en) 1996-04-04 1998-01-27 Mercator Genetics Hereditary hemochromatosis diagnostic markers and diagnostic methods
JP4017672B2 (ja) 1996-10-01 2007-12-05 バイオ‐ラッド ラボラトリーズ，インコーポレーテッド ヒト・ヘモクロマトーシス遺伝子の領域における多型および新規遺伝子
US5879892A (en) 1997-04-25 1999-03-09 Ludwig Institute For Cancer Research Leukemia associated genes
US5879908A (en) 1997-04-30 1999-03-09 Smithkline Beecham Corporation CRFG-1a, a target and marker for chronic renal failure
DE69739334D1 (de) * 1997-07-16 2009-05-07 Metacure N V Einrichtung zur Steuerung eines glatten Muskels
US5916154A (en) * 1998-04-22 1999-06-29 Nellcor Puritan Bennett Method of enhancing performance in pulse oximetry via electrical stimulation
EP1079890A4 (de) * 1998-05-08 2008-12-03 Genetronics Inc Elektrisch induzierte gefässdilation
US6284732B1 (en) 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
US6464687B1 (en) * 1999-03-09 2002-10-15 Ball Semiconductor, Inc. Implantable drug delivery system
US6355425B1 (en) * 1999-03-26 2002-03-12 Billups-Rothenberg, Inc. Mutations associated with iron disorders
US6300108B1 (en) * 1999-07-21 2001-10-09 The Regents Of The University Of California Controlled electroporation and mass transfer across cell membranes
US6927049B2 (en) * 1999-07-21 2005-08-09 The Regents Of The University Of California Cell viability detection using electrical measurements
US20060085046A1 (en) * 2000-01-20 2006-04-20 Ali Rezai Methods of treating medical conditions by transvascular neuromodulation of the autonomic nervous system
US6287608B1 (en) * 2000-04-11 2001-09-11 Intellicardia, Inc. Method and apparatus for treatment of congestive heart failure by improving perfusion of the kidney by infusion of a vasodilator
US7993325B2 (en) * 2002-09-20 2011-08-09 Angio Dynamics, Inc. Renal infusion systems and methods
WO2004075948A2 (en) * 2003-02-24 2004-09-10 Plc Systems, Inc. A method and catheter system applicable to acute renal failure
PL1696812T3 (pl) * 2003-12-24 2015-12-31 Univ California Ablacja tkanki nieodwracalną elektroporacją
US20060067972A1 (en) * 2004-06-23 2006-03-30 Flowmedica, Inc. Devices for renal-based heart failure treatment
US7373204B2 (en) * 2004-08-19 2008-05-13 Lifestim, Inc. Implantable device and method for treatment of hypertension
US20060069323A1 (en) * 2004-09-24 2006-03-30 Flowmedica, Inc. Systems and methods for bi-lateral guidewire cannulation of branched body lumens
US20060074453A1 (en) * 2004-10-04 2006-04-06 Cvrx, Inc. Baroreflex activation and cardiac resychronization for heart failure treatment

Also Published As

Publication number Publication date
AU4030300A (en) 2000-10-16
US6355425B1 (en) 2002-03-12
EP1165840B1 (de) 2008-09-17
US20080187931A1 (en) 2008-08-07
AU779052B2 (en) 2005-01-06
CA2368802A1 (en) 2000-10-05
AU2005201467B9 (en) 2008-10-30
DE60040276D1 (de) 2008-10-30
US6509442B1 (en) 2003-01-21
AU2005201467B2 (en) 2008-04-24
NZ514582A (en) 2004-01-30
US20030129595A1 (en) 2003-07-10
US6955875B2 (en) 2005-10-18
EP1165840A1 (de) 2002-01-02
AU779052C (en) 2000-10-16
CA2368802C (en) 2010-12-21
WO2000058515A1 (en) 2000-10-05
US20060051806A1 (en) 2006-03-09
AU2005201467A1 (en) 2005-05-05

Similar Documents

Publication Publication Date Title
DK0705903T3 (da) Mutationer i det 17q-koblede bryst- og ovariecancerprædisponeringen
ATE408708T1 (de) Mutationen in verbindung mit eisenerkrankungen
DE69333461D1 (de) VERFAHREN ZUM nachweis der Alzheimer Krankheit
NO970625D0 (no) 17q-koblete bryst- og ovariekreft mottagelighetsgener
DK0826042T3 (da) Genetiske sekvenser og problemer med forbindelse til Alzheimers sygdom samt anvendelse deraf
WO2000037679A3 (en) Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis
EP1319408A4 (de) Arzneimittel für herzversagen
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
DE60109430D1 (de) An entzündlichen darmerkrankungen beteiligte gene und deren verwendung
Saha et al. Ablating putative Ku70 phosphorylation sites results in defective DNA damage repair and spontaneous induction of hepatocellular carcinoma
WO2002062197A3 (en) Markers for disease susceptibility and targets for therapy
EA200300246A1 (ru) Ген и белок, ассоциированные с шизофренией
GB9722027D0 (en) Methods
NO985280D0 (no) Anvendelse av en mutasjon i genet for human G-protein 3 subenhet for diagnostisering av sykdommer
EP1298216A4 (de) Verfahren zur behandlung unter verwendung eines enzyms
ATE323408T1 (de) Transgenes tiermodell für neurodegenerative erkrankungen
ATE381260T1 (de) Transgene hergestellte antithrombin iii und deren mutanten
DE60031539D1 (de) Mutiertes nurr1 gen
TW200517502A (en) Methods for detecting Alzheimer's disease
DE602004030107D1 (de) Suszeptibilitätsgen für die alzheimersche krankheit
ATE408686T1 (de) Chondrosarcom-assoziierte gene
TWI266805B (en) Method of detecting genetic disorders
WO2003088919A3 (en) Compositions and methods for diagnostics and therapeutics for hydrocephalus
DE69500393D1 (de) Verfahren zur identifizierung von lymphozyten mit mutator-phänotypen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee